Advertisement

Topics

BioAxone Therapeutic Inc. Company Profile

08:28 EST 13th December 2018 | BioPortfolio

BioAxone’s strategy is to become the world’s dominant bio-pharmaceutical company targeting Rho and Rho-related pathways with the purpose of developing drugs that meet large unmet medical needs. Rho being a signaling pathway which plays a key role in many disease indications, BioAxone has successfully developed a protein based inhibitor for local acute administration, as well as a family of small molecule inhibitors with improved specificity and systemic formulation potential. Both compound families (protein and chemical analogs) are aimed at disease indications for which important medical needs exist but that are not addressed satisfactorily by existing approved therapies: Spinal Cord Injury (“SCI”), Age-related Macular Degeneration (“AMD”) and Glaucoma

Location

7150 rue Frederick-Banting, Suite 200
Saint-Laurent
Quebec
H4S 2A1

Contact

Phone: (514) 282-9990
Fax: (514) 282-9990
Email: info@bioaxone.com


News Articles [100 Associated News Articles listed on BioPortfolio]

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, as part of the...

BioAxone BioSciences CEO Lisa McKerracher Speaker at NeuroTrauma2018 Conference

-Platform Talk on Update on Clinical Trials in Spinal Cord Injury- BioAxone BioSciences, Inc., a biotechnology company focused on developing innovative drugs to treat n...

BioAxone BioSciences Receives Notice of Allowance for Composition of Matter Patent Covering Novel ROCK2 Inhibitor

-Strengthens patent portfolio of Rho Kinase 2 inhibitors- BioAxone BioSciences, Inc., a biotechnology company focused on developing innovative drugs to treat neurotrauma and n...

BioAxone BioSciences’ Scientific Advisory Board Member, Mark Bear, PhD, Receives $500,000 ...

Annual Award Recognizes Transformative Breakthroughs in Vision Research Read more...

BioAxone BioSciences Receives Notice of Allowance on Patent for Treatment of Cerebral Cavernous Malformations and Cerebral Aneurysms with Rho Kinase Inhibitors

Further strengthens BioAxone’s patent portfolio for Rho Kinase 2 inhibitors BioAxone BioSciences, Inc., a biotechnology company focused on developing innovativ...

BioAxone BioSciences’ Scientific Advisory Board Member, Mark Bear, PhD, Receives $500,000 Beckman-Argyros Vision Research Award

Annual Award Recognizes Transformative Breakthroughs in Vision Research BioAxone BioSciences, Inc., a biotechnology company focused on developing innovative drug...

BioAxone BioSciences Awarded Fast-Track SBIR Grant for Continued Development of Rho Kinase 2 Inhibitor

Award to investigate ability of a Rho Kinase 2 inhibitor to improve outcomes in chronic spinal cord injury BioAxone BioSciences, Inc. announced today the receipt of a Fast-Tra...

BioAxone BioSciences Awarded $1.1 Million Phase 2 SBIR Funding for Continued Development of sd-rxRNA Drug Candidate for the Treatment of Spinal Cord Injury

Award based on accomplishment of 1-year milestones; Collaborator RXi Pharmaceuticals to receive a portion of the allotted funding BioAxone BioSciences, Inc. announced today th...

Drugs and Medications [0 Results]

None

PubMed Articles [695 Associated PubMed Articles listed on BioPortfolio]

Pharmacokinetic and pharmacodynamic considerations in the design of therapeutic antibodies.

The design and development of therapeutic monoclonal antibodies through optimizing their pharmacokinetic (PK) and pharmacodynamic (PD) properties is crucial to improve efficacy while minimizing advers...

EGFL7 - a potential therapeutic target for multiple sclerosis?

Toxicological evaluation of therapeutic and supra-therapeutic doses of Cellgevity® on reproductive function and biochemical indices in Wistar rats.

The misconception about dietary supplements being safe has led many into the in-patient wards. Cellgevity® (CGV) is a Max International premiere antioxidant supplement formula used by a large populat...

Updates in Therapeutic Endoscopic Ultrasonography.

The last decade has seen a dramatic rise in the possibilities of therapeutic endoscopic ultrasound (EUS). From EUS fine needle aspiration of cancerous lesion to pseudocyst drainage, it has now not onl...

Early Therapeutic Intervention for IgG4-related Dacryoadenitis and Sialadenitis: The Balance Between Risk of Observation Only and Therapeutic Adverse Effects.

Clinical Trials [2063 Associated Clinical Trials listed on BioPortfolio]

Effects of Therapeutic Touch in Patients With Female Genital Neoplasia: a Randomized Controlled Clinical Trial

This is a randomized controlled prospective study on the use of therapeutic touch in patients diagnosed with gynecological cancer. The patients will be randomized into three groups: contro...

Platform Therapeutic Education in Heart Failure and Coronary Disease

A first therapeutic education is given before patient's discharge at the hospital, then a dedicated nurse follows patients through the phone,regularly according to patients' needs, continu...

Golimumab Trough Levels in Patients With Ulcerative Colitis

Proactive therapeutic drug monitoring of Anti-TNFs with drug titration to a therapeutic window is associated with favorable long-term therapeutic outcomes in IBD and may be superior to rea...

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

Evaluation of clinical, therapeutic and prognostic relevance of new experimental results as well as optimization of therapeutic models and development of a new algorithm for therapeutic pl...

Therapeutic Drug Monitoring of Cardiac Medications

The investigators will interview patients and providers of patients who have hypertension and are seen in cardiology clinic about ways to discuss therapeutic drug monitoring with patients....

Companies [869 Associated Companies listed on BioPortfolio]

BioAxone Therapeutic Inc.

BioAxone’s strategy is to become the world’s dominant bio-pharmaceutical company targeting Rho and Rho-related pathways with the purpose of developing drugs that meet large unmet medical needs. Rh...

BioAxone BioSciences, Inc.

BioAxone BioSciences is a clinical-stage biotechnology company developing innovative drugs to restore neurological function for patients with Spinal Cord Injuries (SCI) and other ...

The Therapeutic Goods Administration (TGA)

The Therapeutic Goods Administration (TGA) is a unit of the Australian Government Department of Health and Ageing. The TGA carries out a range of assessment and monitoring activities to ensure therape...

Therapeutic Proteins Ltd.,

Therapeutic Proteins Ltd., is a world class global developer and supplier of biosimilar recombinant therapeutic proteins. Manufactured in fully cGMP compliant facilities in Europe and North America, o...

Helios BioSciences

The quick selection at low cost of relevant therapeutic targets is one of today major challenges facing the Biotech companies and pharmaceutical industry. The evaluation of the genes involved in a giv...

More Information about "BioAxone Therapeutic Inc." on BioPortfolio

We have published hundreds of BioAxone Therapeutic Inc. news stories on BioPortfolio along with dozens of BioAxone Therapeutic Inc. Clinical Trials and PubMed Articles about BioAxone Therapeutic Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioAxone Therapeutic Inc. Companies in our database. You can also find out about relevant BioAxone Therapeutic Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record